| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |